Journal of AAPOS
Volume 13, Issue 1 , Pages 91-93, February 2009

Travoprost in children: Adverse effects and intraocular pressure response

Duke University Eye Center, Durham, North Carolina

Received 10 March 2008; accepted 21 August 2008.

Because of the limited ability to perform controlled, randomized studies in children, the safety and effectiveness of topical medications in pediatric glaucoma is sometimes difficult to determine. Although travoprost has been commercially available since 2001, there are no published reports on its use in children. This retrospective study found travoprost to have minimal adverse events in children and to reduce IOP in select cases of pediatric glaucoma.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1091-8531(08)00326-1

doi:10.1016/j.jaapos.2008.08.006

Journal of AAPOS
Volume 13, Issue 1 , Pages 91-93, February 2009

Article Tools